Autopsy report · NCT00574080
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
Cause of deathSlow enrollment
“low accrual”
Life of this trial
- Registered 1 year 5 months after it had already started.
- Ran for about 4 years 8 months before it stopped.
- 20 participants enrolled.
- Results were posted on the registry 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University of Arkansas
- Sponsor type
- University, hospital or other
- Conditions
- Multiple Myeloma
- Interventions
- Interim/Maintenance Dexamethasone; Induction/Consolidation Dexamethasone; Induction/Consolidation Cisplatin; Induction/Consolidation Adriamycin; InductionConsolidation Cyclophosphamide; Induction/Consolidation Etoposide
- Participants
- 20
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.